International Business Times26m
A New Dawn in Cancer Treatment: Immunocine Gives Hope Through Its Revolutionary Immunotherapy
Now, eight years later, Chris credits the treatment with saving his life, calling it nothing short of miraculous. Another ...
Medscape30m
T-DXd Shows Consistent Benefit Across Endocrine-Resistant HR+/HER2-Low Breast Cancer Subgroups
New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...